Quijano, Julito C.
HRN: 22-69-64 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/05/2023
CO-AMOXICLAV 625MG (TAB)
03/05/2023
03/12/2023
PO
500 MG
BID
Abrasions
Waiting Final Action
03/08/2023
CO-AMOXICLAV 625MG (TAB)
03/08/2023
03/11/2023
PO
625mg
TID
Abrasions
Waiting Final Action